EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Zinc and Its Antioxidant Properties: The Potential Use of Blood Zinc Levels as a Marker of Cancer Risk in BRCA1 Mutation Carriers

Milena Matuszczak iD, Adam Kiljańczyk, Wojciech Marciniak iD, Róża Derkacz iD, Klaudia Stempa, Piotr Baszuk, Marta Bryśkiewicz, Ping Sun, Angela Cheriyan, Cezary Cybulski, Tadeusz Dębniak iD, Jacek Gronwald iD und 18 weitere

Antioxidants · 16.05.2024 · 13 (5) · 609

DOI: 10.3390/antiox13050609 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antioxidants, online erschienen am 16.05.2024. Verfasst von Milena Matuszczak und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, ul. Unii Lubelskiej 1, 71-252 Szczecin, …. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Minister of Science and Higher Education Grant "Regional Excellence Initiative", Minister of Science and Higher Education “Regional Initiative of Excellence”.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BRCA1 mutations predispose women to breast and ovarian cancer. The anticancer effect of zinc is typically linked to its antioxidant abilities and protecting cells against oxidative stress. Zinc regulates key processes in cancer development, including DNA repair, gene expression, and apoptosis. We took a blood sample from 989 female BRCA1 mutation carriers who were initially unaffected by cancer and followed them for a mean of 7.5 years thereafter. There were 172 incident cases of cancer, including 121 cases of breast cancer, 29 cases of ovarian cancers, and 22 cancers at other sites. A zinc level in the lowest tertile was associated with a modestly higher risk of ovarian cancer compared to women with zinc levels in the upper two tertiles (HR = 1.65; 95% CI 0.80 to 3.44; p = 0.18), but this was not significant. Among those women with zinc levels in the lowest tertile, the 10-year cumulative risk of ovarian cancer was 6.1%. Among those in the top two tertiles of zinc level, the ten-year cumulative risk of ovarian cancer was 4.7%. There was no significant association between zinc level and breast cancer risk. Our preliminary study does not support an association between serum zinc level and cancer risk in BRCA1 mutation carriers.

Schlagwörter

Stichwörter der Autor:innen

BRCA 1breast cancercancer riskcancerogenesisovarian cancerprospective study

Autor:innen und Institutionen

  • Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, ul. Unii Lubelskiej 1, 71-252 Szczecin, Poland.
  • Read-Gene, Grzepnica, ul. Alabastrowa 8, 72-003 Dobra, Poland.
  • Women's College Research Institute, Women's College Hospital, University of Toronto, Toronto, ON M5G 1N8, Canada.
  • Department of Clinical Genetics and Pathology, University of Zielona Góra, ul. Zyty 28, 65-046 Zielona Góra, Poland.
  • Department of Surgery and Oncology, University of Zielona Góra, Zyty 28, 65-046 Zielona Góra, Poland.
  • OPEN, Kazimierza Wielkiego 24 St., 61-863 Poznań, Poland.

ORCID-Profile: Milena Matuszczak, Wojciech Marciniak, Róża Derkacz, Tadeusz Dębniak, Jacek Gronwald, Anna Jakubowska, Marek Szwiec, Małgorzata Stawicka-Niełacna, Andrzej Jasiewicz, Tomasz Kluz, Joanna Tomiczek-Szwiec, Rodney J Scott, Steven A Narod, Jan Lubiński

Förderung

  • Minister of Science and Higher Education Grant "Regional Excellence Initiative"
  • Minister of Science and Higher Education “Regional Initiative of Excellence”

Zitieren

APA

Matuszczak, M., Kiljańczyk, A., Marciniak, W., Derkacz, R., Stempa, K., Baszuk, P., Bryśkiewicz, M., Sun, P., Cheriyan, A., Cybulski, C., Dębniak, T., Gronwald, J., Huzarski, T., Lener, M. R., Jakubowska, A., Szwiec, M., Stawicka-Niełacna, M., Godlewski, D., Prusaczyk, A., …, & Lubiński, J. (2024). Zinc and Its Antioxidant Properties: The Potential Use of Blood Zinc Levels as a Marker of Cancer Risk in BRCA1 Mutation Carriers. Antioxidants, 13(5), 609. https://doi.org/10.3390/antiox13050609

Vancouver

Matuszczak M, Kiljańczyk A, Marciniak W, Derkacz R, Stempa K, Baszuk P, et al. Zinc and Its Antioxidant Properties: The Potential Use of Blood Zinc Levels as a Marker of Cancer Risk in BRCA1 Mutation Carriers. Antioxidants. 2024;13(5):609. doi:10.3390/antiox13050609

BibTeX
@article{Matuszczak2024,
  author = {Matuszczak, Milena and Kiljańczyk, Adam and Marciniak, Wojciech and Derkacz, Róża and Stempa, Klaudia and Baszuk, Piotr and Bryśkiewicz, Marta and Sun, Ping and Cheriyan, Angela and Cybulski, Cezary and Dębniak, Tadeusz and Gronwald, Jacek and Huzarski, Tomasz and Lener, Marcin R and Jakubowska, Anna and Szwiec, Marek and Stawicka-Niełacna, Małgorzata and Godlewski, Dariusz and Prusaczyk, Artur and Jasiewicz, Andrzej and Kluz, Tomasz and Tomiczek-Szwiec, Joanna and Kilar-Kobierzycka, Ewa and Siołek, Monika and Wiśniowski, Rafał and Posmyk, Renata and Jarkiewicz-Tretyn, Joanna and Scott, Rodney J and Narod, Steven A and Lubiński, Jan},
  title = {Zinc and Its Antioxidant Properties: The Potential Use of Blood Zinc Levels as a Marker of Cancer Risk in BRCA1 Mutation Carriers},
  journal = {Antioxidants},
  year = {2024},
  volume = {13},
  number = {5},
  pages = {609},
  doi = {10.3390/antiox13050609}
}
Kostenlos starten →